Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by Emory University
Sponsor:
Collaborators:
Schering-Plough
Genentech, Inc.
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Jeffrey James Olson, Emory University
ClinicalTrials.gov Identifier:
NCT01435395
First received: September 14, 2011
Last updated: December 15, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)